Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/bju.15400 | DOI Listing |
Minerva Urol Nephrol
November 2024
Department of Urology, Hannover Medical School, Hannover, Germany -
J Surg Case Rep
November 2024
Department of Surgery, Jawaharlal Nehru Medical College, Medical College Road, Aligarh Muslim University, Aligarh 202002, India.
Angiomyolipoma is a benign mesenchymal tumour of kidney that consists of adipose tissue, muscle cells and blood vessels. Renal angiomyolipomas represent almost one percent of all renal tumours. We reported a case of a 50-year-old woman complaining of mild abdominal discomfort with no other symptoms and no remarkable medical history.
View Article and Find Full Text PDFBJR Open
January 2024
Department of Radiation Oncology, Chris O'Brien Lifehouse, Sydney 2050, Australia.
Background: Wilms tumour, a common paediatric cancer, is difficult to treat in low- and middle-income countries due to limited access to imaging. Artificial intelligence (AI) has been introduced for staging, detecting, and classifying tumours, aiding physicians in decision-making. However, challenges include algorithm accuracy, translation into conventional diagnosis, reproducibility, and reliability.
View Article and Find Full Text PDFLangenbecks Arch Surg
October 2024
Department of Urology and Urosurgery, Medical Faculty Mannheim, University Medical Centre Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Purpose: Evaluation of a kidney-adjusted enhanced recovery after surgery (ERAS) protocol (kERAS) in patients undergoing nephron-sparing surgery (PN).
Methods: The kERAS protocol is a multidimensional protocol focusing on optimized perioperative fluid and nutrition management as well as strict intraoperative and postoperative blood pressure limits. It was applied in a prospective cohort (n = 147) of patients undergoing open or robotic PN.
Urol Oncol
October 2024
Henry Ford Health, Detroit, MI. Electronic address:
Robot-assisted partial nephrectomy (RAPN) has readily become the benchmark treatment of small renal masses (SRMs). The management of SRMs is focused on preserving renal function and limiting the morbidity of a traditional open operation, thus greatly impacting overall prognosis and long-term survival. Indications and techniques have evolved over the last 2 decades.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!